Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-07-03
DOI
10.1093/carcin/bgz127
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation
- (2018) Angela Russo et al. ONCOGENE
- The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus
- (2018) Matthew Dean et al. Hormones & Cancer
- Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas
- (2018) Thing Rinda Soong et al. JOURNAL OF PATHOLOGY
- UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
- (2018) Laura Hardy et al. Cancers
- Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer
- (2018) Matthew Dean et al. CARCINOGENESIS
- The fallopian tube, “precursor escape” and narrowing the knowledge gap to the origins of high-grade serous carcinoma
- (2018) Thing Rinda Soong et al. GYNECOLOGIC ONCOLOGY
- LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions
- (2017) Elisa Schmoeckel et al. MODERN PATHOLOGY
- PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state
- (2017) Kholoud Alwosaibai et al. Oncotarget
- Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide
- (2016) Naveena Singh et al. GYNECOLOGIC ONCOLOGY
- PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer
- (2016) D A Modi et al. ONCOGENE
- Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators
- (2016) Georgette Moyle-Heyrman et al. Journal of Ovarian Research
- Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer
- (2016) Natividad Gomez-Roman et al. Oncotarget
- Divergent Roles of PAX2 in the Etiology and Progression of Ovarian Cancer
- (2015) E. M. Al-Hujaily et al. Cancer Prevention Research
- The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium
- (2014) Gang Ning et al. JOURNAL OF PATHOLOGY
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- PAX2 Expression in Ovarian Cancer
- (2013) Huijuan Song et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Conditional Inactivation of p53 in Mouse Ovarian Surface Epithelium Does Not Alter MIS Driven Smad2-Dominant Negative Epithelium-Lined Inclusion Cysts or Teratomas
- (2013) Suzanne M. Quartuccio et al. PLoS One
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor
- (2013) Hisham Mohammed et al. Cell Reports
- PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer
- (2011) Charles M Quick et al. MODERN PATHOLOGY
- PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype
- (2011) David Beauchemin et al. Molecular Cancer
- Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
- (2010) Richard J. Santen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression
- (2010) Michael H Roh et al. MODERN PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started